Site articles.


Avoidable blindness – A growing burden

Up-to-date global and regional estimates of vision loss have recently been published in the Lancet Global Health by the Vision Loss Expert Group (VLEG). The research reviewed population-based surveys of eye disease from 1980 to 2018 and compared them to the World Health Assembly Global Action Plan (WHA GAP) target of a 25% global reduction from […]

Read more →

Australia commits $500m for COVID-19 vaccine in Pacific & South East Asia

Vision 2020 Australia has welcomed the Australian Government’s announcement of an additional $500 million over three years to provide safe and effective COVID-19 vaccines in the Pacific and Southeast Asia. The funding will be used to distribute COVID-19 vaccine doses throughout the Indo-Pacific region and provide technical support to ensure vaccine safety, efficacy and quality […]

Read more →

RANZCO welcomes new President and launches the Heather G Mack Scholarship for Women

The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Council met via Zoom on Saturday 10 October 2020. The main orders of business were the approval of the College’s 2021-2023 Strategic Plan the approval of the College’s first-ever Sustainability Charter. Both these documents, plus the annual report are available on the RANZCO website. The […]

Read more →

Luxturna becomes first ever TGA approved gene therapy

In a landmark decision, the Therapeutic Goods Administration has approved use of the first ever gene therapy in Australia. Luxturna (voretigene neparvovec) is now registered in Australia, for the treatment of patients with inherited retinal dystrophy caused by pathological biallelic RPE65 mutations, who have sufficient viable retinal cells as determined by the treating physician. Luxturna […]

Read more →